NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
A food science journal has retracted a French study linking genetically modified foods to tumors and organ failure in rats that went viral on the Internet. Elsevier, the publisher of the journal, Food and Chemical Toxicity, said it was ...
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
Anti-malarial treatments that act on a new target have the potential to cure, prevent and block the transmission of the disease, U.S. researchers said. The as-yet undeveloped treatments would target an enzyme essential for the growth and ...
Tags: Anti-malarial, treatment, act, target, parasite
Posted in Printing Equipment and Supplies by Qmed Staff on November 25, 2013 Innovations in 3-D printing have allowed researchers to fabricate human bones, ears, early-prototype human hearts, strips of liver and face prosthetics. In the ...
A look back through our archives sees that DuPont, Dr Pepper, Post Holdings and Ralcorp Holdings, Kraft Foods and Dow Chemical Company have all had issues to address. General Mills is working to undo the impact of poor waste disposal more ...
Tags: Changing, environmental, issue, food, firm
US-based CSL Behring has announced the availability of DNA1 Advanced Alpha-1 Screening (DNA1), a new test kit designed to improve diagnosis of Alpha-1 antitrypsin deficiency (Alpha-1). Alpha-1 is a serious hereditary condition that is ...
Tags: Diagnosing Kit, CSL Behring
Following U.S. Food and Drug Administration actions, USPLabs in Texas recalled and destroyed a supplement linked to liver failure and hepatitis, officials say. "As soon as we suspected a possible link between OxyElite Pro products and ...
The Direxion Torqueable Microcatheter-a microcatheter for shrinking tumors or blocking aneurysms-has won FDA and CE Mark approval, Boston Scientific recently announced. The FDA granted the Direxion a 510(k) clearance because it retains ...
Tags: Boston Scientific Microcatheter, FDA Approval, Direxion a 510(k)
Biotronik, a manufacturer of cardiovascular medical devices, has obtained the US Food and Drug Administration (FDA) approval for Phase B of the company’s ongoing ProMRI clinical trial. Biotronik has recently completed Phase A of the ...
Tags: Promri Clinical Trial, Biotronik
The US Food and Drug Administration (FDA) has approved Janssen Therapeutics' NS3/4A protease inhibitor 'Olysio (simeprevir)' for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with ...
Posted in Cardiovascular by Qmed Staff on November 22, 2013 Researchers at the Cardiovascular Innovation Institute hope to create a 3-D-printed bioartificial heart in the next decade. The bioartificial heart would be designed from a ...
Boston Scientific, a medical device company, has obtained the US Food and Drug Administration clearance and CE Mark approval for its Direxion torqueable microcatheter, designed to facilitate selective access and delivery of diagnostic, ...
Tags: Boston Scientific, Microcatheter